| __timestamp | Amneal Pharmaceuticals, Inc. | Grifols, S.A. |
|---|---|---|
| Wednesday, January 1, 2014 | 785623000 | 3355384000 |
| Thursday, January 1, 2015 | 866280000 | 3934563000 |
| Friday, January 1, 2016 | 1018225000 | 4049830000 |
| Sunday, January 1, 2017 | 1033654000 | 4318073000 |
| Monday, January 1, 2018 | 1662991000 | 4486724000 |
| Tuesday, January 1, 2019 | 1626373000 | 5098691000 |
| Wednesday, January 1, 2020 | 1992523000 | 5340038000 |
| Friday, January 1, 2021 | 2093669000 | 4933118000 |
| Saturday, January 1, 2022 | 2212304000 | 6063967000 |
| Sunday, January 1, 2023 | 2393607000 | 6591977000 |
Igniting the spark of knowledge
In the competitive landscape of the pharmaceutical industry, Grifols, S.A. and Amneal Pharmaceuticals, Inc. have emerged as key players. Over the past decade, Grifols has consistently outpaced Amneal in terms of annual revenue. From 2014 to 2023, Grifols' revenue grew by nearly 97%, reaching approximately $6.6 billion in 2023. In contrast, Amneal's revenue increased by about 205% during the same period, yet it only reached around $2.4 billion in 2023.
Grifols' dominance is evident, with its revenue consistently more than double that of Amneal's each year. This trend highlights Grifols' strong market position and strategic growth initiatives. As the pharmaceutical sector continues to evolve, these companies' financial trajectories offer valuable insights into their competitive strategies and market dynamics.
AstraZeneca PLC vs Amneal Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Novartis AG vs Amneal Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Alnylam Pharmaceuticals, Inc. vs Grifols, S.A.: Annual Revenue Growth Compared
Revenue Insights: Genmab A/S and Amneal Pharmaceuticals, Inc. Performance Compared
Revenue Showdown: Incyte Corporation vs Amneal Pharmaceuticals, Inc.
BioMarin Pharmaceutical Inc. and Grifols, S.A.: A Comprehensive Revenue Analysis
Revenue Insights: Walgreens Boots Alliance, Inc. and Amneal Pharmaceuticals, Inc. Performance Compared
Ascendis Pharma A/S or Amneal Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
Revenue Showdown: Grifols, S.A. vs PTC Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Grifols, S.A. and Amneal Pharmaceuticals, Inc.
Breaking Down Revenue Trends: Amneal Pharmaceuticals, Inc. vs Vericel Corporation
Amneal Pharmaceuticals, Inc. vs Mesoblast Limited: Examining Key Revenue Metrics